Mariah Klunk Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2012

Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariah Klunk Research Topics

Disease

4	Tuberculosis (Tuberculoses) 01/2023 - 01/2012
3	Infections 10/2014 - 01/2012
1	Infertility (Sterility) 01/2023
1	Meningeal Tuberculosis (Tuberculous Meningitis) 12/2016
1	Granuloma 01/2015
1	Coinfection 10/2014
1	Inflammation (Inflammations) 10/2014
1	Klebsiella Infections (Klebsiella Infection) 10/2014
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2014
1	Neoplasms (Cancer) 10/2014
1	Pneumonia (Pneumonitis) 10/2014
1	Pulmonary Tuberculosis 10/2014

Drug/Important Bio-Agent (IBA)

2	AerosolsIBA 10/2014 - 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	N,N- diethyl- 2- (2- (4- methoxyphenyl)- 5,7- dimethyl- pyrazolo(1,5- a)pyrimidin- 3- yl)- acetamideIBA 01/2015
1	2-deoxy-2-fluorosorbitolIBA 10/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	CytokinesIBA 01/2012
1	Etanercept (Enbrel)FDA Link 01/2012

Therapy/Procedure

3	Therapeutics 01/2023 - 10/2014
1	Duration of Therapy 01/2023
1	Drug Therapy (Chemotherapy) 10/2014